Murine Ia and human DR antigens were isolated and purified by immunoprecipitation and sodium dodecyl sulfate/polyacrylamide gel electrophoresis with allo-and xenoantisera, respectively. The I-A subregon antigen consists of two chains, designated Aa 
homologous if a single amI o acidshift is imposed on one of those chains. Thus, human DR antigens strongly resemble the murine IC subregion antigens. The genetic region I of the murine major histocompatibility complex contains genes that control immune responses and regulate interactions among T cells, B cells, and macrophages (1, 2) . These interactions, which are required to generate cellular and humoral immunity, are believed to be mediated by cell-surface molecules identified serologically and known as immune response-associated (Ia) alloantigens (3) . By using specific alloantisera produced by cross-immunization of I region incompatible murine strains, two sets of la alloantigens have been identified. One, determined by the I-A subregion, consists of two chains of approximately 26,000 and 35,000 daltons (4, 5) ; the other, determined by the I-C region, also consists of two chains with similar sizes (6, 7) . 1 1 Based on partial NH2-terminal sequence analysis, these two sets of molecules appear to be unrelated (6) (7) (8) .
On the basis of tissue distribution (for review, see refs. 3 and 9) and functional (10, 11) and biochemical (10) (11) (12) criteria, a human counterpart of murine I region antigens has been identified. These human antigens are referred to as DR antigens because of their relationship to the HLA-D region of the human major histocompatibility complex, which appears to be an analog of the murine I region (13, 14) . The aim of this study was to characterize the molecular structure and the primary amino acid sequence of human DR antigens by using the microsequencing technique developed for murine histocompatibility antigens and to compare them with the structural properties of murine Ta antigens. Specific xenoantiserum that react serologically with the same antigenic structures as DR alloantisera (12, 15) was used for the purification of DR antigens. The data
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presented reveal some striking similarities and differences between murine I-C and human DR antigens.
MATERIALS AND METHODS
Murine Ia Antigens. The methods used for the isolation, purification, and sequence analysis of Ia alloantigens from murine spleen cells are identical to those previously published (6) . The serological properties of the alloantisera (B10 X HTI)F1 anti-B1O.A (5R) and (A.TH X B1O.HTT)F1 anti-A.TL, used to isolate I-C subregion and I-A subregion molecules from B10.D2 and B10.A (4R) mice, respectively, have also been described (16) . Human (17) . Mem- brane glycoproteins were extracted with the nonionic detergent Nonidet-P40, and soluble glycoproteins were isolated by affinity chromatography on Lens culinaris lectin-Sepharose 4B (17) . Crystalline ovalbumin (1 mg/ml) was added to the isolated glycoprotein as a carrier protein.
DR antigens were isolated from the purified glycoprotein by indirect immunoprecipitation with heat-killed, formalinfixed, protein A-bearing Staphylococcus aureus (SACI) prepared as described by Kessler (18) . Briefly, three successive reactions were carried out by overnight incubation at 40 of the lentil lectin eluate with 250 ,l of antiserum 3634, followed by a 2-hr adsorption of the immune complexes with 2.5 ml of 10% S. aureus preparation. The antigen-loaded bacteria were washed and antigens were eluted from them as described (17) .
The two chains that comprise the DR antigen were separated by sodium dodecyl sulfate/polyacrylamide gel electrophoresis as described by Laemmli (19) . Both chains were isolated and subjected to NH2-terminal sequence analysis as described for the murine Ia antigens (6).
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Proc. Nati. Acad. Sci. USA 75 (1978) RESULTS The electrophoresis profiles of murine Ia alloantigens determined by the I-A and I-C subregions and of human DR antigens are shown in Fig. 1 . The I-A subregion molecule consists of two chains, designated Aa and Ad, with approximate molecular weights of 35,000 and 26,000, respectively. Under nonreducing conditions, both chains migrated slightly more rapidly than when reduced and a large component (molecular weight, 55,000) was observed. This large component is a disulfide-linked a:3 dimer because the relative amounts of a and fl monomer were similar under reducing and nonreducing conditions. The I-C subregion molecule similarly consists of two chains, designated Ca and Cp, with approximate molecular weights of 32,000 and 29,000, respectively. Under nonreducing conditions, the migration rate of the (3 chain changed dramatically, resulting in an apparent molecular weight of 24,000, but the migration rate of the a chain changed only minimally. The net effect is to increase the resolution of the a and ( chains. The DR antigen consists of two chains, a and (, with molecular weights of 34,000 and 28,000, respectively. Under nonreducing conditions, there was again a dramatic change in migration rate of the (3 chains, analogous to that observed for the I-C region antigen, resulting in an apparent molecular weight of 24,000.
The partial NH2-terminal sequences of both chains comprising the I-C and DR antigens were determined. The sequence data and repetitive yields (92-96%) were comparable to those previously obtained for murine histocompatibility antigens (5) . Detailed data of sequence analyses will be published elsewhere. The partial NH2-terminal sequences for both chains of I-C and DR antigens are shown in Fig. 2 . Each residue assignment is based on at least two independent analyses in the amino acid sequencer. In addition, the NH-terminal sequences of chains p34 and p29, which comprise a B cell-surface marker isolated and sequenced by more conventional methods (20) , are shown for comparison. E UL DISCUSSION The availability of highly specific alloantisera to murine I region gene products has greatly facilitated identification and biochemical characterization of Ia alloantigens. Based on previous studies (4-7), as well as those reported here, the I-A and I-C molecules show several structural differences. The I-C polypeptide chains have molecular weights of 32,000 and 29,000 and differ slightly from the I-A polypeptide chains (molecular weights of 35,000 and 26,000). In addition, some I-A molecules exist as disulfide-linked a(3 dimers. These dimers are not artifacts because I-C molecules isolated under identical conditions do not display any dimeric forms. Similar dimeric forms of guinea pig Ia alloantigens have been observed (21) . Structural differences, if any, between dimeric and monomeric I-A molecules are unknown. The presence of dimeric and monomeric forms may represent an equilibrium between the two which reflects some physiological function.
Intriguingly, although the Aa, A,6, and Ca chains migrate at similar rates under reducing and nonreducing conditions, the C,6 chain migrates much more rapidly when not reduced, suggesting an apparent decrease in the molecular weight. This probably reflects the presence of an intrachain disulfide bond which, when maintained, keeps the molecule in more compact form than when this bond is reduced and the Can chain becomes more linear. This conformational change would affect the rate at which the C, chain migrates through the sodium dodecyl sulfate/polyacrylamide gels.
In order to compare the structure of human DR antigens to that of murine Ia antigens, the former were isolated and purified with xenoantisera. Several lines of evidence indicate that the xenoantisera react with the same antigenic structures as do the DR alloantisera. Both react with B lymphoid cells (15, 22, 23) and are potent inhibitors of mixed lymphocyte reactions (10, 11, 15, 24) . Also, incubation of target cells with F(ab)2 fragments of xenoantisera (12, 25) (6, 7, 26) as well as shifts in molecular weights of presumedly HLA-D locus gene products p29 and p34 have been observed previously (20) . The 
